Multiple Sclerosis/ Demyelinating Disease

Contributing journals to this collection:
JAMA & Archives Journals

Citations 141-150 of 370 total displayed.

Past content

Original Contributions
Inhibition by Mitoxantrone of In Vitro Migration of Immunocompetent Cells: A Possible Mechanism for Therapeutic Efficacy in the Treatment of Multiple Sclerosis

Tea Kopadze; Thomas Dehmel; Hans-Peter Hartung; Olaf Stüve; Bernd C. Kieseier
Arch Neurol 2006; 63: 1572-1578. [Abstract] [Full text] [PDF]  

Original Contributions
Interferon Inhibitory Activity in Patients With Multiple Sclerosis

Kailash Chadha; Bianca Weinstock-Guttman; Robert Zivadinov; Kavitha Bhasi; Jason Muhitch; Joan Feichter; Miriam Tamaño-Blanco; Nadir Abdelrahman; Julian Ambrus Sr; Frederick Munschauer; Murali Ramanathan
Arch Neurol 2006; 63: 1579-1584. [Abstract] [Full text] [PDF]  

Original Contributions
Altered CD4⁺/CD8⁺ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

Olaf Stüve; Christina M. Marra; Amit Bar-Or; Masaaki Niino; Petra D. Cravens; Sabine Cepok; Elliot M. Frohman; J. Theodore Phillips; Gabriele Arendt; Keith R. Jerome; Linda Cook; Francois Grand'Maison; Bernhard Hemmer; Nancy L. Monson; Michael K. Racke
Arch Neurol 2006; 63: 1383-1387. [Abstract] [Full text] [PDF]  

Original Contributions
High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis

Douglas E. Gladstone; Kenneth W. Zamkoff; Lauren Krupp; Robert Peyster; Patrick Sibony; Christopher Christodoulou; Emily Locher; Patricia K. Coyle
Arch Neurol 2006; 63: 1388-1393. [Abstract] [Full text] [PDF]  

Original Contributions
Potential for Interferon Beta–Induced Serum Antibodies in Multiple Sclerosis to Inhibit Endogenous Interferon-Regulated Chemokine/Cytokine Responses Within the Central Nervous System

Aaron M. Shapiro; Carolyn S. Jack; Yves Lapierre; Nathalie Arbour; Amit Bar-Or; Jack P. Antel
Arch Neurol 2006; 63: 1296-1299. [Abstract] [Full text] [PDF]  

Original Contributions
Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis

Ralph H. B. Benedict; Jared M. Bruce; Michael G. Dwyer; Nadir Abdelrahman; Sarah Hussein; Bianca Weinstock-Guttman; Neeta Garg; Frederick Munschauer; Robert Zivadinov
Arch Neurol 2006; 63: 1301-1306. [Abstract] [Full text] [PDF]  

Original Contributions
High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis

Douglas E. Gladstone; Kenneth W. Zamkoff; Lauren Krupp; Robert Peyster; Patrick Sibony; Christopher Christodoulou; Emily Locher; Patricia K. Coyle
Arch Neurol 63.10.noc60076. [Abstract] [Full text] [PDF]  

Original Contributions
Regional Gray Matter Atrophy in Early Primary Progressive Multiple Sclerosis: A Voxel-Based Morphometry Study

Jorge Sepulcre; Jaume Sastre-Garriga; Mara Cercignani; Gordon T. Ingle; David H. Miller; Alan J. Thompson
Arch Neurol 2006; 63: 1175-1180. [Abstract] [Full text] [PDF]  

Neurological Reviews
Plasma Exchange in Neuroimmunological Disorders: Part 1: Rationale and Treatment of Inflammatory Central Nervous System Disorders

Helmar C. Lehmann; Hans-Peter Hartung; Gerd R. Hetzel; Olaf Stüve; Bernd C. Kieseier
Arch Neurol 2006; 63: 930-935. [Abstract] [Full text] [PDF]  

Original Contributions
Type 1 Diabetes and Multiple Sclerosis: A Danish Population-Based Cohort Study

Nete M. Nielsen; Tine Westergaard; Morten Frisch; Klaus Rostgaard; Jan Wohlfahrt; Nils Koch-Henriksen; Mads Melbye; Henrik Hjalgrim
Arch Neurol 2006; 63: 1001-1004. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37